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Abstract OBJECTIVES: Preterm deliveries represent still one of the most important prob-
lems in contemporary obstetrics. They are associated with prematurity and 
higher rate of perinatal mortality and morbidity. During the last few years, the 
role of C-reactive protein (CRP) in prediction of threatening preterm delivery 
was emphasized. CRP is produced mainly inside the liver as a response to acute 
and chronic inflammatory processes. 
AIM: The aim of this study was to assess relations between C-reactive protein, 
oxytocinase, izooxytocinase and vaginal culture in prediction of preterm deliv-
ery. 
METHODS: This study was performed in the years 2000–2004 in the Depart-
ment of Septic Obstetrics and Gynecology of Collegium Medicum of the Jagiello-
nian University. Some 389 patients hospitalized because of threatening preterm 
delivery or preterm delivery in tractu were enrolled into the trial. 
CONCLUSION : C-reactive protein is a useful marker of threatening preterm 
delivery, overtaking the results of vaginal culture. CAP1 and CAP2 are effective 
biochemical markers in pregnancy monitoring.
Introduction
Preterm deliveries still belong to one of the 
most important problems in contemporary 
obstetrics. Prevalence of preterm deliveries in 
Poland ranges from 7.4 to 8.2% [17]. They are 
associated with prematurity and higher rate of 
perinatal mortality and morbidity. Management 
of the preterm delivery generally is based on the 
following schedule [10, 17, 21]: 
1) inhibition of the contractile activity of the 
uterus,
2) choice of the mode of delivery,
3) intrauterine stimulation of maturation of the 
lungs of fetus by steroids,
4) cooperation between obstetricians and pediat-
rics in care of prematurely delivered infant.
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Infections of vagina, cervix and urinary tract play 
significant role in etiology of preterm delivery [4, 6, 17, 
18]. According to Divers M. and Lilford R., infections 
can cause up to 40 % of preterm deliveries [2]. 
There are some biochemical markers, which when 
elevated, may indicate an inflammatory process (fetal 
fibronectin, interleukin 6, interleukin 8, tumor necro-
sis factor or C-reactive protein) [3, 8, 17]. 
During the last few years, the role of C-reactive 
protein (CRP) in prediction of threatening preterm 
delivery was emphasized [1, 13, 15, 20]. CRP is pro-
duced mainly inside the liver as a response to acute 
and chronic inflammatory processes [15]. This is a part 
of nonspecific immunological response of human body. 
Production of CRP is induced by interleukin 1 (IL-1), 
interleukin 6 (IL-6) and tumor necrosis factor (TNF) 
[19]. It takes part in opsonization of microbes, classi-
cal activation of the complement and has influence on 
many human cells: macrophages, granulocytes, lym-
phocytes and platelets [19, 20]. 
During infection, there is increase of CRP within 2 
to 5 hours before clinical symptoms of infection [13]. 
It is difficult to define the correct value of CRP in 
blood sample of pregnant women. Beck K. et al. con-
cluded in their review that most authors choose the 
upper limit of CRP at 8–20 mg/l in normal pregnancy 
[1]. 
According to contemporary trends, the role of as-
sessment of CRP in pregnant women with preterm 
contractile activity of the uterus becomes more signifi-
cant in monitoring of the threatening preterm deliv-
ery. Hvilson H. et al. observed, that CRP level over 9.9 
mg/l has positive predictive value in respect of higher 
risk of the preterm delivery [7]. 
Aim
The aim of this study was to assess relations be-
tween C-reactive protein, oxytocinase, izooxytocinase 
and vaginal culture in prediction of preterm delivery. 
Material and methods
This study was performed in the years 2000–2004 in 
the Department of Septic Obstetrics and Gynecology 
of Collegium Medicum of the Jagiellonian University. 
Some 389 patients hospitalized because of threatening 
preterm delivery or preterm delivery in tractu were 
enrolled into the trial. Information about patients was 
collected retrospectively from information cards. Fol-
lowing factors were analyzed:
1) age,
2) parity,
3) gestational age at the time of hospitalization,
4) way of delivery, if patients delivered,
5) C-reactive protein (CRP) value in maternal blood 
sample (positive result was considered over 7ng/l),
6) results of microbiological examination of discharge 
from the vagina, if it was taken,
7) premature rupture of membranes,
8) using of steroids for the stimulation of fetal lung 
maturation,
9) level of oxytocinase and izooxytocinase if it was 
measured,
10) antibiotics treatment,
11) Apgar score of delivered infant at first minute. 
 Results of this study are presented in tables and 
graphs. 
Results
The mean age of general population (N=389) was 
27.52 ± 6.12 (range: 15–46); 49.87% patients were 
primagravidae. Gestational age during hospitalization 
was 29.63 ± 4.3 weeks (range: 23–36). Preterm rupture 
of membranes occurred in 45 patients (11.57). Posi-
tive results of CRP test were obtained for 162 women 
(41.65%). Antibiotics treatment was administrated 
to 203 pregnant women (52.19%). The most common 
antibiotics were penicillin and cefalosporyn (graph.1). 
Dexaven was used in 122 patients (31.36%). Summary 
about general population is presented in Table 1.
Preterm delivery occurred in 169 patients [n2] 
(43.44%) at 30.85 ± 4.34 gestational weeks (range: 22–
36). 106 (62.72%) of patients underwent vaginal deliv-
ery and 63 (37.28%) cesarean section (Table 2). Gen-
eral condition of neonates at first minute after delivery 
according to Apgar score was 6.93 ± 3.06 points (Table 
2). Positive value of CRP was in 96 women (56.80%). 
Patients who delivered preterm underwent therapy 
with steroids in 57 cases (33.73%). The mean value of 
oxytocinase was 5,6 ± 3,6 (range: 1,8–13,6) and izooxy-
tocinase 4,6 ± 3,4 (range: 2,2–11,2). Antibiotics were 
administrated in 127 patients (75.15%). Preterm rup-
ture of membranes occurred in 42 cases (24.85%). In 
107 (63.31%) patients discharge from the vagina was 
cultured – 75 (70.09%) positive results. Escherichia 
coli were the most common microbe (graph.2). 
The rest of 220 patients [n1] (56.56%) were hos-
pitalized at 28.7 ± 4.03 of gestational weeks (range: 
22–36). Inside this group positive results of CRP were 
obtained for 66 pregnant women (30%). Culture of 
discharge from the vagina was performed in 212 cases 
(96.36%) – 98 (46.23) positive results were collected. 
Candida albicans was the most common infectious fac-
tor (13.2%) (graph.3). Preterm rupture of membranes 
occurred in 3 cases (1.36%). 76 (34.55%) of pregnant 
women underwent antibiotics therapy; 65 (29.55%) 
steroids therapy. The mean value of oxytocinase was 
4,4 ± 2,4 (range: 1,4–11,2) and 4 ± 1,8 (range: 1,8–8) of 
izooxytocinase.
Relation between patients with threatening 
preterm delivery [n1=220] and patients who delivered 
prematurely [n2=169] are shown in Table 3.
Comments
This study has shown that the elevated level of 
CRP is associated with an increased risk of preterm 
delivery (56.80% vs 30%). The similar indications were 
C-reactive protein as a predictor of threatening preterm delivery
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presented by Mazor et al. These authors reported re-
sults from women in preterm delivery and found that 
the mean CRP level in a subgroup of women with a 
CRP level above 8mg/l was higher in women deliver-
ing preterm than in women delivering at term [13]. 
They also suggested that the mean gestational age 
on admission and the mean gestational age at deliv-
ery were significantly lower in women with increased 
CRP levels than in women with low CRP levels [13]. In 
our groups there were no difference in average age on 
admission and at delivery. According to Ghezzi F. et al. 
amniotic fluid CRP concentration over 110 ng/ml has a 
sensitivity of 80% and a specificity of 70% in prediction 
of spontaneous preterm delivery below 34 gestational 
weeks [5]. This study confirms the theory that sub-
clinical intrauterine inflammatory process in gesta-
tion may be important for the occurrence of preterm 
delivery [5]. 
We observed that inside the second group, the anti-
biotics therapy was administrated more often than in 
the first one (75.15% vs 34.55%). It’s probably related 
to the fact, that inside the second group preterm rup-
ture of membranes occurred more often (24.85% vs 
1.36%). There were not observed any differences in 
gestational age (28.7 weeks vs 30.85 weeks) and using 
of steroids between groups (29.55% vs 33.73). 
One of the most useful biochemical markers in 
monitoring pregnancy is oxytocinase (CAP1) and 
izooxytocinase (CAP2). The first descriptions of oxi-
tocin-oxytocinase axis and oxitocin-izooxitocinase 
axis were presented in 60’s by Klimek R. [9]. These 
aminopeptidase’s can regulate many physiological 
processes and inhibit contractile effect of oxytocine. 
Placenta is mainly responsible for their production 
[11]. According to Klimek R. and Klimek M. increasing 
level of CAP1 and CAP2 grants proper development of 
Table 2. Patient’s who preterm delivered (n2–169).
Variables Value
Gestational age (weeks) 30,85±4,34 (22–36)*
Cesaream section 63 (37,28%)**
Vaginal delivery 106 (62,72%)**
Condition of neonates (Apgar score) 6,93±3,06 (0–10)*
* mean value ± standard deviation (maximal value – minimal 
value) 
** number of patients 
Table 1. Basic information about general population 
(N=389).
Variables Value
Patient age (years) 27,52±6,12 (15 – 46)*
Gestational age (weeks) 29,63±4,3 (22 – 36)*
Primagravida 194 (49,87%) **
Multigravida 195 (50,13%)**
PROM 45 (11,57%)**
Antibiotics therapy 203 (52,19%)**
Steroids therapy 122 (31,36%)**
Positive CRP 162 (41,65%)**
Preterm delivery 169 (43,44%)**
* mean value ± standard deviation (maximal value – minimal 
value) 
** number of patients 
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Table 3. Relation between patients with threatening preterm delivery (n1) and patients who preterm
 delivered (n2). 
Variables
Value
n1 n2
Number 220 (56,56%)** 169 (43,44%)**
Gestational age (weeks) 28,7±4,03 (22–36)* 30,85±4,34 (22–36)*
Positive CRP 66 (30%)** 96 (56,80%)**
PROM 3 (1,36%)** 42 (24,85%)**
Positive vaginal culture 98/212 (46,23%)** 75/107 (70,09%)**
The most common pathogen Candida albicans Escherichia coli
Antibiotics therapy 76 (34,55%)** 127 (75,15%)**
Steroids therapy 65 (29,55%)** 57 (33,73%)**
Oxytocinase (CAP1) 4,4±2,4 (1,4–11,2)* 5,6±3,6 (1,8–13,6)*
Izooxytocinase (CAP2) 4±1,8 (1,8–8)* 4,6±3,4 (2,2–11,2)*
* mean value ± standard deviation (maximal value – minimal value) 
** number of patients 
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Graph 1. The most common used antibiotics.
Graph 2. Vaginal culture within group of patients who preterm delivered (169)
Graph.3. Vaginal culture within group of patients with threatening of preterm delivery (220). 
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the pregnancy, while decreasing level allow to predict 
possibility of preterm delivery [11, 12]. The role of 
these two biochemical markers in pregnancy monitor-
ing is unquestionable also in some obstetrics complica-
tion such as: pregnancy induced hypertension or ges-
tational diabetes mellitus [9]. In our study there was 
no significant differences of CAP1 and CAP2 between 
groups. It indicates that the infectious factor played 
the most important role in induction of preterm deliv-
ery – 70.09% positive vaginal culture in patients who 
preterm delivered. Contractile activity of the uterus 
was not related to oxitocine but to inflammatory me-
diators such as: prostaglandins, leukotriens, tumor ne-
crosis factor, interleukins and tromboxans. We claimed 
that positive CRP overtake positive vaginal culture 
and allow to administrate antibiotics therapy quicker 
than normal. It prevents from dissemination of infec-
tious factor and obstetrical complications. 
Effectiveness of assessment C-reactive protein in 
pregnancy monitoring is confirmed by many authors 
in different ways. Redman et al. postulated that CRP 
concentration is higher in patients in whom pre-
eclampsia subsequently develop than in those patients 
who had uncomplicated pregnancy [16]. Minakami 
H. et al. showed relation between CRP level, white 
blood cell count and cerclage. They concluded, that 
preoperative concentration of CRP below 4 mg/ml, 
white blood cell count below 14000/ml and dilation of 
the cervix below 4 cm prolong pregnancy after cerclage 
[14]. Hvilson G. et al. claimed, that a high CRP level at 
the beginning of a pregnancy is associated with nearly 
twofold increased risk of preterm delivery, however the 
clinical value at this point is still limited [7].
The role of CRP in prediction of preterm delivery 
is unquestionable, specially when infectious factor is 
responsible for induction of preterm contractile activ-
ity of uterus. Assessment of CRP should be joined with 
CAP1 and CAP2 to increase the quality of prenatal 
care. 
Conclusions
1) C-reactive protein is a useful marker of threaten-
ing preterm delivery, overtaking the significance of 
vaginal culture.
2) CAP1 and CAP2 are effective biochemical markers 
in pregnancy monitoring.
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